Found: 42
Select item for more details and to access through your institution.
Real‐time analysis of the cancer genome and fragmentome from plasma and urine cell‐free DNA using nanopore sequencing.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 12, p. 1, doi. 10.15252/emmm.202217282
- By:
- Publication type:
- Article
Detection of Circulating Tumor Cells Using the Attune NxT.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 21, doi. 10.3390/ijms24010021
- By:
- Publication type:
- Article
Tumor-educated platelet blood tests for Non-Small Cell Lung Cancer detection and management.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-35818-w
- By:
- Publication type:
- Article
Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0-1 non-small cell lung cancer: the INCREASE trial.
- Published in:
- 2020
- By:
- Publication type:
- Journal Article
89 Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5546, doi. 10.3390/cancers15235546
- By:
- Publication type:
- Article
Relationship between Treatment Plan Dosimetry, Toxicity, and Survival following Intensity-Modulated Radiotherapy, with or without Chemotherapy, for Stage III Inoperable Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5923, doi. 10.3390/cancers13235923
- By:
- Publication type:
- Article
The Analysis of Platelet-Derived circRNA Repertoire as Potential Diagnostic Biomarker for Non-Small Cell Lung Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4644, doi. 10.3390/cancers13184644
- By:
- Publication type:
- Article
Identification of protein biomarkers for prediction of response to platinum‐based treatment regimens in patients with non‐small cell lung cancer.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 6, p. 1417, doi. 10.1002/1878-0261.13555
- By:
- Publication type:
- Article
Compact portable multiphoton microscopy reveals histopathological hallmarks of unprocessed lung tumor tissue in real time.
- Published in:
- Translational Biophotonics, 2020, v. 2, n. 4, p. 1, doi. 10.1002/tbio.202000009
- By:
- Publication type:
- Article
How to obtain the image-derived blood concentration from <sup>89</sup>Zr-immuno-PET scans.
- Published in:
- EJNMMI Physics, 2024, v. 11, n. 1, p. 1, doi. 10.1186/s40658-024-00621-7
- By:
- Publication type:
- Article
The Effect of Preanalytical and Physiological Variables on Cell-Free DNA Fragmentation.
- Published in:
- Clinical Chemistry, 2022, v. 68, n. 6, p. 803, doi. 10.1093/clinchem/hvac029
- By:
- Publication type:
- Article
Pharmacokinetic analysis of [F]FAZA in non-small cell lung cancer patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 10, p. 1523, doi. 10.1007/s00259-013-2462-3
- By:
- Publication type:
- Article
Effects of erlotinib therapy on [C]erlotinib uptake in EGFR mutated, advanced NSCLC.
- Published in:
- EJNMMI Research, 2016, v. 6, n. 1, p. 1, doi. 10.1186/s13550-016-0169-8
- By:
- Publication type:
- Article
Focal <sup>18</sup>F‐FDG uptake predicts progression of pre‐invasive squamous bronchial lesions to invasive cancers.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 9, p. 840, doi. 10.1111/1759-7714.14815
- By:
- Publication type:
- Article
The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection.
- Published in:
- Genome Biology, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13059-023-03074-w
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small- cell lung cancer . .
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of<sup> 89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [ <sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [ 18F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantification of PD‐L1 expression with [<sup>18</sup>F]BMS‐986192 PET/CT in patients with advanced stage non‐small‐cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Quantitative and Simplified Analysis of <sup>11</sup>C-Erlotinib Studies.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 6, p. 861, doi. 10.2967/jnumed.115.165225
- By:
- Publication type:
- Article
Multiparametric Analysis of the Relationship Between Tumor Hypoxia and Perfusion with <sup>18</sup>F-Fluoroazomycin Arabinoside and <sup>15</sup>O-H<sub>2</sub>O PET.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 4, p. 530, doi. 10.2967/jnumed.115.166579
- By:
- Publication type:
- Article
Parametric Methods for Quantification of <sup>18</sup>F-FAZA Kinetics in Non-Small Cell Lung Cancer Patients.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 11, p. 1772, doi. 10.2967/jnumed.114.141846
- By:
- Publication type:
- Article
Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response to ICI therapy.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 1, p. 1, doi. 10.1002/cti2.1363
- By:
- Publication type:
- Article
Relationship between Biodistribution and Tracer Kinetics of 11 C-Erlotinib, 18 F-Afatinib and 11 C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 4, p. 883, doi. 10.3390/diagnostics12040883
- By:
- Publication type:
- Article
Stereotactic ablative radiotherapy in patients with early-stage non-small cell lung cancer and co-existing interstitial lung disease.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
The development process of 'fit-for-purpose' imaging biomarkers to characterize the tumor microenvironment.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1347267
- By:
- Publication type:
- Article
Radiolabeled EGFR TKI as predictive imaging biomarkers in NSCLC patients – an overview.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.900450
- By:
- Publication type:
- Article
Loose Tumor Cells in Pulmonary Arteries of Lung Adenocarcinoma Resection Specimens: No Correlation With Survival, Despite High Prevalence.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2024, v. 148, n. 5, p. 588, doi. 10.5858/arpa.2023-0009-OA
- By:
- Publication type:
- Article
<sup>89</sup>Zr-immuno-PET using the anti-LAG-3 tracer [<sup>89</sup>Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 2068, doi. 10.1007/s00259-023-06164-w
- By:
- Publication type:
- Article